LEVY RAPHI (Chief Financial Officer) sold 18.0% of their position (32.50K shares) of ALPHA TAU MEDICAL LTD. on the open market
Open‑market sale worth $352.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/4/2026ACC: 0001213900-26-065201
Officer· Chief Financial Officer
Since Mar 2026
-32.50K
Net shares
Net seller
$352.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
32.50K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
−17.50K
Price / share
$10.90
Trade value
$190.76K
% of position
9.7%
6/3/2026
180.18K→162.68K
Ordinary Shares
Direct
Shares
−15K
Price / share
$10.76
Trade value
$161.36K
% of position
9.2%
6/3/2026
162.68K→147.68K
Total
Net shares
−32.50K
Net value
-$352.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/3/2026 | S · Sale | −17.50K | $10.90 | $190.76K | 9.7% | 180.18K | 162.68K |
| Ordinary Shares Direct | 6/3/2026 | S · Sale | −15K | $10.76 | $161.36K | 9.2% | 162.68K | 147.68K |
| Total | −32.50K | -$352.12K | ||||||
Derivative Transactions0
No derivative transactions reported